Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels

Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels

US Patent 5786332 · Granted Jul 28, 1998

Estimated economic value: $466,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Development of potential antidotes for arsenicals2025
Composition for treating blood cancer using 4′-thio-5-Aza-2′-deoxycytidine and u2025
Modulators of programmed death-ligand-1 and/or programmed death-ligand-22024
Compounds for the treatment of acute and chronic kidney disease2024
Selective small molecule peptidomimetic melanocortin ligands2024
2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative disease2024
Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) 2023
Compounds for the treatment of acute and chronic kidney disease2023
2,5-aryl-thiazole analogs for the treatment of neurodegenerative diseases2023
Compounds for the treatment of acute and chronic kidney disease2023
Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) 2022
Piperazine-2,5-diones as TGF-beta inhibitors2022